Tchaikapharma High Quality Medicines AD

Research Tchaikapharma High Quality Medicines AD (THQM) on Bullrun: market cap EUR 871.18M, P/E 280.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 871.18M; P/E is 280.1.

Peer valuation comparison

Latest P/E is 280.12x versus a Bulgaria median of 17.92x (1463.2% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 32.74MEUR 3.08Mn/a71.8%0.03EUR 610.00Kn/an/a
FY2024EUR 27.24MEUR 2.30Mn/a70.1%0.02EUR 70.00Kn/an/a
FY2023EUR 24.80MEUR 1.74Mn/a30.9%0.02EUR 30.00Kn/an/a
FY2022EUR 22.06MEUR 1.43Mn/a70.3%0.01EUR 70.00Kn/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-14EUR 871.18M280.1n/an/a

Related stock research

Other related stocks

Frequently asked questions

What is Tchaikapharma High Quality Medicines AD's market cap?

Tchaikapharma High Quality Medicines AD's market capitalization is EUR 871.18M.

What is Tchaikapharma High Quality Medicines AD's P/E ratio?

Tchaikapharma High Quality Medicines AD's price-to-earnings (P/E) ratio is 280.1.